CYP3A4 and Decreased liver function: Interestingly, we expected that participants with CP who were on CAT would show a correlation between elevated ROC dosing and serum ALT, which is a surrogate indicator of the liver dysfunction that has been linked increased ROC catabolism by CYP3A [39,41,42].